A proportion of NMO patients are seropositive to aquaporin 4 (AQP4) antibody (Lennon et al., 2004, 2005), a membrane bound water channel that is preferentially expressed at the end feet of astrocytes (Amiry-Moghaddam et al., 2003). This evidence concerns the gene AQP4 and neuromyelitis optica.